ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Accrued Interest Receivable, Net
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Accrued Interest Receivable, Net of $319.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2018-08-07
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2018-03-31 was $319.00K, a 11.27% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2017-09-30 was -$546.91K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2017-06-30 was $227.14K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2017-03-31 was $359.51K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month |
|---|---|---|---|
| 2018-03-31 | $319.00K 10-Q · filed 2018-05-10 | ||
| 2017-09-30 | -$546.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$319.77K derived: sum of 2 quarters · filed 2018-08-07 | $39.74K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $227.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $586.65K 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $359.51K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |